PURIOLABS, LLC — Department of Defense SBIR Phase II: DHA SEQUENTIAL PHASE II SBIR PURITALL STERILIZER - SEQUENTIAL PHASE II
PURIOLABS, LLC — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- At $1,946,974, this is a large obligation for typical SBIR Phase sizing — worth reviewing for scope breadth and teaming opportunity.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Puriolabs LLC received nearly $1.95 million from the Defense Health Agency for a Phase II SBIR project to advance the Puritall Sterilizer. This sequential award supports further development of sterilization technology for military health applications.
- Amount
- $1,946,974
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- TX
- Period
- 2025-09-05 → 2028-01-04
Technology domains
Description
DHA SEQUENTIAL PHASE II SBIR PURITALL STERILIZER - SEQUENTIAL PHASE II